Thrombomodulin (TM) is a surface glycoprotein of endothelial cells involved
in both anticoagulation and antifibrinolysis, In this study, we assessed t
he clinical significance of TM in acute liver damage by using a rat model i
nduced by intraperitoneal injection of D-galactosamine (Gal-N). Serum TM le
vels were measured with enzyme immunoassay utilizing rabbit anti-rat TM ant
ibody. Simultaneously, immunohistochemical examination was performed using
the same antibody. Serum TM levels increased significantly after the inject
ion of Gal-N compared with preinjection levels, peaking from 48 to 72 hours
after injection and normalizing by 168 hours. Changes in parenchymal damag
e were synchronized with changes of TM, and changes of TM levels mirrored c
hanges of liver weight. In immunohistochemical examination, TM immunoreacti
vity was observed only on the endothelial surfaces of both the artery and p
ortal vein within Glisson's sheath in controls. After injection of Gal-N, T
M immunoreactivity was gradually intensified, especially around the necroti
c area and the central veins. These findings disappeared with improvement o
f parenchymal damage. Both the increase of serum TM levels and intensified
TM immunoreactivity in the liver were synchronized with acute liver parench
ymal damage induced by Gal-N. These findings on TM are related to endotheli
al damage with parenchymal necrosis and liver regeneration interacting with
both homeostasis of microcirculation and healing of parenchymal damage. (C
) 1999 Elsevier Science Ltd.